These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 13833205)

  • 1. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 2. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F; DIEMER K
    Med Exp Int J Exp Med; 1960; 3():249-51. PubMed ID: 13712856
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental pathology of iproniazid and related compounds.
    ZBINDEN G; STUDER A
    Ann N Y Acad Sci; 1959 Sep; 80():873-84. PubMed ID: 13847126
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of iproniazid and beta-phenylisopropylhydrazine (JB516) on the narcotic effect and decomposition of hexobarbital and thiopental].
    ARRIGONI-MARTELLI E; KRAMER M
    Med Exp Int J Exp Med; 1959; 1():45-51. PubMed ID: 13794503
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 8. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of metrazol-in-duced seizures by iproniazid and betaphenylisopropylhy-drazine in mice.
    SPOERLEIN MT; ELLMAN AM
    Arch Int Pharmacodyn Ther; 1961; 133():193-9. PubMed ID: 13915887
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 14. The application of a monoamine-oxidase inhibitor, I-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertension.
    GILLESPIE L; TERRY LL; SJOERDSMA A
    Am Heart J; 1959 Jul; 58(1):1-12. PubMed ID: 13661056
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
    BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M
    Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of 2 monoamine oxidase inhibitors (iproniazid and JB 516) in the therapy of arterial hypertension.
    ORVIS HH; TAMAGNA IG; THOMAS RE
    Am J Med Sci; 1959 Sep; 238():336-43. PubMed ID: 14429171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.